Response to baricitinib therapy in patients with rheumatoid arthritis with inadequate response to csDMARDs as a function of baseline characteristics
Joel M Kremer, Michael Schiff, David Muram, Jinglin Zhong, Jahangir Alam, Mark C Genovese
RMD Open Jan 2018, 4 (1) e000581; DOI: 10.1136/rmdopen-2017-000581
